<DOC>
	<DOCNO>NCT01546454</DOCNO>
	<brief_summary>Women regular menstrual cycle low risk heart disease men age woman longer menstrual cycle . The purpose study help determine menstrual cycle cause low risk heart disease . The investigator believe hormone ( estradiol progesterone ) produce menstrual cycle , well normal process occur follicle corpus luteum ( transformed follicle ) , change level `` good '' `` bad '' cholesterol blood-stream . These level good bad cholesterol important risk factor heart disease . Therefore , goal determine effect factor ( estradiol , progesterone , follicle , corpus luteum ) level good bad cholesterol woman 's bloodstream . As many woman take birth control pill , contain synthetic form estradiol progesterone block ovulation development corpus luteum , investigator also want determine effect one common type birth control pill level good bad cholesterol .</brief_summary>
	<brief_title>Relationship Between Menstrual Cycle Heart Disease Women</brief_title>
	<detailed_description>Premenopausal woman low age-adjusted risk coronary heart disease ( CHD ) men postmenopausal woman . This decreased risk CHD likely due , part , favorable lipid profile observe premenopausal woman . The menstrual cycle associate ovarian process follicular growth ovulation , corpus luteum ( CL ) development , function , regression . The steroid estrogen ( E2 ) progesterone ( P4 ) secrete follicle CL , travel via bloodstream elicit effect target tissue . The production E2 implicate menstrual cycle-associated factor underlie favorable lipid profile know increase atheroprotective high density lipoprotein decrease atherogenic low density lipoprotein . However , factor may play role direct ovarian metabolism circulate lipid . Furthermore , role P4 unclear evidence may inhibit beneficial effect E2 . Therefore , aim determine contribution ovarian metabolism lipid , independent effect ovarian-derived E2 P4 , circulate lipid profile premenopausal woman . Also , determine relationship E2 P4 , natural synthetic form find hormonal oral contraceptive , circulate lipid . With recent controversial finding Women 's Health Initiative , evaluation factor underlie menstrual cycle protection CHD warrant . This study may implications management CHD use hormonal therapy woman .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Normal menstrual cycle 2535 day length least previous 3 cycle 2140 year age BMI &gt; 18 , &lt; 30 Serum P4 &gt; 9 ng/ml single sample collect day 1825 selfreported menstrual cycle Flexible schedule allow morning blood draw le 48 hour notice In good general health Commit remain stable diet study period ( change normal dietary habit ) Commit use nonhormonal contraceptive method study period except prescribed experimental protocol No objection take study drug Oral contraceptive use hormone supplement within precede 2 month Longacting hormonal contraceptive use past 12 month ( e.g. , DepoProveraÂ® ) Contraindications study drug Current past pregnancy within previous 6 month currently try conceive Desiring conceive next 8 month Breastfeeding past 2 month Diagnosed Diabetes Metabolic Syndrome Current previous use cholesterol lower drug within precede 12 month Diagnosed Polycystic Ovary Syndrome History , selfreported , substance abuse Smoker Previous infertility treatment exclude male factor issue Use investigational drug within past 2 month</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Premenopausal woman</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>menstrual cycle</keyword>
	<keyword>lipid</keyword>
</DOC>